Click Here to return To Results

 

Rituximab as Treatment for anti-MuSK myasthenia gravis Neurol 89:1069-1077, Hehir, M.K.,et al, 2017 See this aricle in Pubmed Article Abstract This study provides Class IV evidence that for patients with anti-MuSK MG, rituximab increased the probability of a favorable outcome.

Related Tags

(click to filter results - removes previous filter) efficacy monoclonal antibodies MuSK antibodies myasthenia gravis myasthenia gravis,treatment of rituximab treatment of neurologic disorder

Click Here to return To Results